Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Atrium Therapeutics, Inc. in the last 12 months.
There are not yet two fiscal years of reported share counts for Atrium Therapeutics, Inc..
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PT
Price T Rowe Associates Inc /MD/
|
1.5M | 8.65% | −80.2K (−5.2%) | Q1 '26 | 0.0% | |
|
Shares held by quarter
Peak holding1.6M (Q1'26)
Change over 8 quarters+1.5M
Share of the company8.650%
|
||||||
|
SC
Sessa Capital IM, L.P.
|
1.5M | 8.80% | +948.6K (+172.0%) | Q1 '26 | 0.3% | |
|
Shares held by quarter
Peak holding1.5M (Q2'26)
Change over 8 quarters+1.5M
Share of the company8.800%
|
||||||
28 more super investors behind a free account
See every manager holding Atrium Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
TR
T. Rowe Price Health Sciences Fund, Inc.
|
$7.62M | 566.4K | 3.32% | 0.06% | June 30, 2026 |
|
VT
Vanguard Index Funds
|
$6.97M | 518.4K | 3.04% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Atrium Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BS
Boyce Sarah
Insider
|
138.7K | 0.81% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.810%
|
||||||
|
GK
Gallagher Kathleen P.
Insider
|
119.7K | 0.70% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.700%
|
||||||
9 more holders behind a free account
See every insider and 5%+ holder of Atrium Therapeutics, Inc..
Sign up freeLoading...